Oncology & Cancer

New strategy likely to speed drug development for rare cancers

Researchers have identified promising new therapies for ependymoma, a rare tumor with few treatment options. St. Jude Children's Research Hospital investigators led the effort, which used a new, faster drug development system ...

Neuroscience

Team develops first of a kind in-vitro 3-D neural tissue model

Researchers at the University of Illinois at Urbana-Champaign have successfully used stem cells to engineer living biohybrid nerve tissue to develop 3-D models of neural networks with the hopes of gaining a better understanding ...

Diseases, Conditions, Syndromes

Reinventing drug discovery: Promising drug target for ALS

Using a new stem-cell based drug screening technology with the potential to reinvent and greatly reduce the cost of the way new pharmaceuticals are developed, Harvard Stem Cell Institute (HSCI) researchers have found a compound ...

Medical research

Potential new drug target for cystic fibrosis

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Regensburg University, both in Germany, and the University of Lisboa, in Portugal, have discovered a promising potential drug target for cystic ...

Diseases, Conditions, Syndromes

Researchers work to develop screening method for superbug

A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its ...

Medications

Repurposed drugs present new strategy for treating COVID-19

A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays. The research team suggested the strategy for virtual screening ...

page 4 from 13